Alpa Laboratories Limited

NSEI:ALPA Voorraadrapport

Marktkapitalisatie: ₹2.3b

Alpa Laboratories Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Alpa Laboratories heeft een totaal eigen vermogen van ₹1.6B en een totale schuld van ₹22.6M, wat de schuld-eigenvermogensverhouding op 1.4% brengt. De totale activa en totale passiva bedragen respectievelijk ₹2.0B en ₹343.6M. De EBIT Alpa Laboratories is ₹80.0M waardoor de rentedekking -3.7 is. Het heeft contanten en kortetermijnbeleggingen van ₹1.1B.

Belangrijke informatie

1.4%

Verhouding schuld/eigen vermogen

₹22.61m

Schuld

Rente dekkingsratio-3.7x
Contant₹1.09b
Aandelen₹1.65b
Totaal verplichtingen₹343.55m
Totaal activa₹1.99b

Recente financiële gezondheidsupdates

Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Jan 19
Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Recent updates

Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now

Sep 22
Increases to Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation Might Cool off for now

Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market

Sep 06
Alpa Laboratories Limited's (NSE:ALPA) Shares Bounce 32% But Its Business Still Trails The Market

We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Jun 08
We Think That There Are Issues Underlying Alpa Laboratories' (NSE:ALPA) Earnings

Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Jun 03
Cautious Investors Not Rewarding Alpa Laboratories Limited's (NSE:ALPA) Performance Completely

Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Dec 14
Here's Why We Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With Alpa Laboratories Limited's (NSE:ALPA) CEO Compensation And Here's Why

Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Aug 26
Here's Why Alpa Laboratories (NSE:ALPA) Has Caught The Eye Of Investors

Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Jan 19
Is Alpa Laboratories (NSE:ALPA) A Risky Investment?

Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

Jun 17
Is Now The Time To Put Alpa Laboratories (NSE:ALPA) On Your Watchlist?

If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Feb 23
If You Like EPS Growth Then Check Out Alpa Laboratories (NSE:ALPA) Before It's Too Late

Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Nov 24
Alpa Laboratories' (NSE:ALPA) Earnings Aren't As Good As They Appear

Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Oct 05
Here's Why I Think Alpa Laboratories (NSE:ALPA) Might Deserve Your Attention Today

Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

May 31
Do Alpa Laboratories's (NSE:ALPA) Earnings Warrant Your Attention?

With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Jan 28
With EPS Growth And More, Alpa Laboratories (NSE:ALPA) Is Interesting

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₹1.8B ) ALPA } overtreffen de korte termijn passiva ( ₹319.6M ).

Langlopende schulden: De kortetermijnactiva ALPA ( ₹1.8B ) overtreffen de langetermijnschulden ( ₹24.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ALPA heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van ALPA is de afgelopen 5 jaar gestegen van 0.3% naar 1.4%.

Schuldendekking: De schuld van ALPA wordt goed gedekt door de operationele kasstroom ( 446.8% ).

Rentedekking: ALPA verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y